Skip to content
The Policy VaultThe Policy Vault

Mulpleta (lusutrombopag)Blue Cross Blue Shield of Oklahoma

Other FDA labeled indications

Initial criteria

  • Diagnosis of thrombocytopenia with chronic liver disease
  • Baseline platelet count < 50 x 10^9/L prior to therapy
  • Scheduled to undergo a procedure with associated risk of bleeding (e.g., gastrointestinal endoscopy, liver biopsy, bronchoscopy, dental procedure)
  • Would require platelet transfusion unless platelet counts are increased from baseline